ENFERMEDADES REUMÁTICAS
Vall d'Hebron Institut de Recerca
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Vall d'Hebron Institut de Recerca (1)
2019
-
Budget impact analysis of subcutaneous belimumab in patients with systemic lupus erythematosus in Spain
ClinicoEconomics and Outcomes Research, Vol. 11, pp. 757-765